Mevo operates a digital-prescription platform focused on popularizing electronic prescriptions through B2B channels, with hospitals as its principal clients. The company is present in about 1,100 hospital units including Rede D'Or, Hospital Sírio-Libanês and Beneficência Portuguesa, and expects hospitals and clinics to generate 50 million prescriptions this year versus 35 million last year. Mevo serves 130 municipal health secretariats and reports that more than 1.4 million SUS patients have used its digital prescriptions. After acquiring competitor Receita Digital, Mevo doubled its number of doctors on the platform to about 100,000 active physicians — roughly 15% of professionals in the country — and estimates reach across all channels of about 15 million patients. Its primary monetization is Mevo Shop, a marketplace connecting prescriptions to 1,600 points of sale including partner chains and its own Mevo Farma, and it also sells exposure to pharmaceutical companies (20 labs currently paying and about 40 in negotiation). The company does not disclose its revenue.

Total raised

$38M

Funding rounds

2

Latest round

Equity

Latest activity

Mar 2026